Status:
COMPLETED
Acetaminophen Transfer Across the Placenta and the Assessment of Fetal Well-being
Lead Sponsor:
Mayo Clinic
Conditions:
Fetal Testing
Transplacental Transfer of Acetaminophen
Eligibility:
FEMALE
18-44 years
Phase:
PHASE1
Brief Summary
This study has two aims: 1. to evaluate placental transfer of acetaminophen from mother to baby transplacentally given from 30 minutes to 24 hours prior to cesarean delivery (34 patients) 2. to under...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Pregnant females
- Age 18-44
- Any race
- Any parity
- Singleton Gestations
- Weight between 60-90 kg
- Exclusion Criteria
- Acetaminophen Allergy
- Contraindication to Acetaminophen Use
- Chorioamnionitis
- Preeclampsia
- Diabetes Mellitus
- Placental Abruption
- Placenta Previa
- Fetal Anomaly
- Intrauterine growth restriction (IUGR)
- Multiple Gestations
- Maternal Medical Disease
- Acetaminophen use in the last 3 days
- Plan to donate or bank fetal cord blood
Exclusion
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT01211912
Start Date
September 1 2010
End Date
December 1 2011
Last Update
September 1 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905